Bionic eyes may soon be available in the U.S.

Retinal prosthesis Argus
Credit: Second Sight

The following is a summary.

For people with retinitis pigmentosa — a rare genetic disease that damages cells in the back of the eye — the world becomes increasingly blurry until they see nothing at all. A new bionic eye could partially restore sight to people with this eye condition, the Wall Street Journal reports, and it may soon gain FDA approval.

The Argus II device, developed by Second Sight, uses a video camera, mounted on a pair of glasses, to collect visual information. It translates the visual information into an electrical signal that stimulates the dead retinal cells at the back of the eye. The retinal cells signal to the brain, and the brain interprets the information into a picture.

“The technology tested to date lets the wearer primarily see in black and white,” writes WSJ. “It is most useful for seeing sharp contrasts, such as the painted white line of a crosswalk on a dark road. But scientists hope that they can improve the detail to eventually enable color vision in its wearers.”

Read the full article here: The Quest to Create a Bionic Eye Gets Clearer

Additional Resources:

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend